Teva has filed a complaint
against nine pharmaceutical companies including Dr Reddy's Laboratories, Sandoz and Mylan for alleged patent infringement over Copaxone (glatiramer acetate injection), a treatment for patients with multiple sclerosis.
The case, which was filed on December 19 in the US District Court for the District of Delaware, arose after each of the nine companies filed an Abbreviated New Drug Application with the Food and Drug Administration.
The other companies which have been sued are Synthon Pharmaceuticals, Momenta Pharmaceuticals, Pfizer, Amneal Pharmaceuticals, Biocon and Apotex.
According to the complaint, the nine companies have allegedly sought approval to market a generic version of Copaxone before the expiration of US patent number 9,402,874, which is owned by Teva.
Teva has asked the court for a judgment that the nine companies have infringed its patent covering Copaxone.
It has also asked the court to enjoin them from bringing the generics to market, as well as for an award of damages.
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
European Patent Office
George Washington Law School
Kirkland & Ellis International LLP
Marks & Clerk
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
The United States Patent and Trademark Office (USPTO)
World Intellectual Property Office
For multi-user price options, or to check if your company has an existing subscription we can add you into for FREE, please contact Atif at firstname.lastname@example.org
If you have any technical issues please email tech support.
Teva, Copaxone, patent, ANDA, FDA, Dr Reddy's, Sandoz, Mylan, Pfizer